Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides

Infection and Immunity

Volumn 74, Issue 7, 2006, Pages 4133-4141

  Avril, Tony ^a,c   Wagner, Eric R ^b   Willison, Hugh J ^b   Crocker, Paul R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c CENTRE EUGÈNE MARQUIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLYCAN DERIVATIVE; LECTIN; LIPOOLIGOSACCHARIDE; SIALIC ACID; SIALIC ACID IMMUNOGLOBULIN LIKE LECTIN 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BINDING ASSAY; CAMPYLOBACTER JEJUNI; CHO CELL; CONTROLLED STUDY; GENETIC TRANSFECTION; GUILLAIN BARRE SYNDROME; HOST CELL; HOST PATHOGEN INTERACTION; LEUKOCYTE; MOLECULAR RECOGNITION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; LECTINS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES, BACTERIAL;

EID: 33745597368     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.02094-05     Document Type: Article

References (41)

1. Angata, T., E. H. Margulies, E. D. Green, and A. Varki. 2004. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc. Natl. Acad. Sci. USA 101:13251-13256.
2. Aspinall, G. O., C. M. Lynch, H. Pang, R. T. Shaver, and A. P. Moran. 1995. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. Eur. J. Biochem. 231:570-578.
3. Aspinall, G. O., A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barre syndrome. Biochemistry 33:241-249.
4. Avril, T., H. Floyd, F. Lopez, E. Vivier, and P. R. Crocker. 2004. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J. Immunol. 173:6841-6849.
5. Avril, T., S. D. Freeman, H. Attrill, R. G. Clarke, and P. R. Crocker. 2005. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. J. Biol. Chem. 280:19843-19851.
6. Blixt, O., B. E. Collins, I. M. van den Nieuwenhof, P. R. Crocker, and J. C. Paulson. 2003. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 278:31007-31019.
7. Bowes, T., E. R. Wagner, J. Boffey, D. Nicholl, L. Cochrane, M. Benboubetra, J. Conner, K. Furukawa, K. Furukawa, and H. J. Willison. 2002. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barr é syndrome. Infect. Immun. 70:5008-5018.
8. Collins, B. E., O. Blixt, A. R. DeSieno, N. Bovin, J. D. Marth, and J. C. Paulson. 2004. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Natl. Acad. Sci. USA 101:6104-6109.
9. Crocker, P. R. 2005. Siglecs in innate immunity. Curr. Opin. Pharmacol. 5:431-437.
10. Crocker, P. R., E. A. Clark, M. Filbin, S. Gordon, Y. Jones, J. H. Kehrl, S. Kelm, N. Le Douarin, L. Powell, J. Roder, R. L. Schnaar, D. C. Sgroi, K. Stamenkovic, R. Schauer, M. Schachner, T. K. van den Berg, P. A. van der Merwe, S. M. Watt, and A. Varki. 1998. Siglecs: a family of sialic-acid binding lectins. Glycobiology 8:v.
11. Crocker, P. R., S. Freeman, S. Gordon, and S. Kelm. 1995. Sialoadhesin binds preferentially to cells of the granulocytic lineage. J. Clin. Investig. 95:635-643.
12. Crocker, P. R., and A. Varki. 2001. Siglecs, sialic acids and innate immunity. Trends Immunol. 22:337-342.
13. Falco, M., R. Biassoni, C. Bottine, M. Vitale, S. Sivori, R. Augugliaro, L. Moretta, and A. Moretta. 1999. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 190:793-802.
14. Godschalk, P. C., A. P. Heikema, M. Gilbert, T. Komagamine, C. W. Ang, J. Glerum, D. Brochu, J. Li, N. Yuki, B. C. Jacobs, A. van Belkum, and H. P. Endtz. 2004. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J. Clin. Investig. 114:1659-1665.
15. Goodyear, C. S., G. M. O'Hanlon, J. J. Plomp, E. R. Wagner, I. Morrison, J. Veitch, L. Cochrane, R. W. Bullens, P. C. Molenaar, J. Conner, and H. J. Willison. 1999. Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J. Clin. Investig. 104:697-708.
16. Hartnell, A., J. Steel, H. Turley, M. Jones, D. G. Jackson, and P. R. Crocker. 2001. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97:288-296.
17. Hickey, T. E., G. Majam, and P. Guerry. 2005. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect. Immun. 73:5194-5197.
18. Hughes, R. A., and D. R. Cornblath. 2005. Guillain-Barre syndrome. Lancet 366:1653-1666.
19. Ikehara, Y., S. K. Ikehara, and J. C. Paulson. 2004. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. J. Biol. Chem. 279:43117-43125.
20. Jones, C., M. Virji, and P. R. Crocker. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49:1213-1225.
21. Jones, M. A., S. Tötemeyer, D. J. Maskell, C. E. Bryant, and P. A. Barrow. 2003. Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni. Infect. Immun. 71:2626-2633.
22. Karlyshev, A. V., D. Linton, N. A. Gregson, and B. W. Wren. 2002. A novel paralogous gene family involved in phase-variable flagella-mediated motility in Campylobacter jejuni. Microbiology 148:473-480.
23. Ketley, J. M. 1997. Pathogenesis of enteric infection by Campylobacter. Microbiology 143:5-21.
24. Kiehlbauch, J. A., R. A. Albach, L. L. Baum, and K.-P. Chang. 1985. Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes. Infect. Immun. 48:446-451.
25. Lanoue, A., F. D. Batista, M. Stewart, and M. S. Neuberger. 2002. Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur. J. Immunol. 32:348-355.
26. Le-Barillec, K., J. G. Magalhaes, E. Corcuff, A. Thuizat, P. J. Sansonetti, A. Phalipon, and J. P. Di Santo. 2005. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol. 175:1735-1740.
27. Linenberger, M. L. 2005. CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance. Leukemia 19:176-182.
28. Lock, K., J. Zhang, J. Lu, S. H. Lee, and P. R. Crocker. 2004. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 209:199-207.
29. Nicoll, G., T. Avril, K. Lock, K. Furukawa, N. Bovin, and P. R. Crocker. 2003. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur. J. Immunol. 33:1642-1648.
30. Nicoll, G., J. Ni, D. Liu, P. Klenerman, J. Munday, S. Dubock, M. G. Mattei, and P. R. Crocker. 1999. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 274:34089-34095.
31. Penner, J. L., and G. O. Aspinall. 1997. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J. Infect. Dis. 176:S135-S138.
32. Prendergast, M. M., and A. P. Moran. 2000. Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J. Endotoxin Res. 6:341-359.
33. Razi, N., and A. Varki. 1999. Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 9:1225-1234.
34. Schnaar, R. L., B. E. Collins, L. P. Wright, M. Kiso, M. B. Tropak, J. C. Roder, and P. R. Crocker. 1998. Myelin-associated glycoprotein binding to gangliosides. Structural specificity and functional implications. Ann. N. Y. Acad. Sci. 845:92-105.
35. Siegesmund, A. M., M. E. Konkel, J. D. Klena, and P. F. Mixter. 2004. Campylobacter jejuni infection of differentiated THP-1 macrophages results in interleukin 1 beta release and caspase-1-independent apoptosis. Microbiology 150:561-569.
36. Wassenaar, T. M., M. Engelskirchen, S. Park, and A. Lastovica. 1997. Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages. Med. Microbiol. Immunol. 186:139-144.
37. Willison, H. J., and N. Yuki. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591-2625.
38. Wooldridge, K. G., and J. M. Ketley. 1997. Campylobacter-host cell interactions. Trends Microbiol. 5:96-102.
39. Yamaji, T., M. Mitsuki, T. Teranishi, and Y. Hashimoto. 2005. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs. Glycobiology 15:667-676.
40. Yamaji, T., T. Teranishi, M. S. Alphey, P. R. Crocker, and Y. Hashimoto. 2002. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. J. Biol. Chem. 277:6324-6332.
41. Yuki, N. 2005. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr. Opin. Immunol. 17:577-582.